{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:34:21Z","timestamp":1790505261227,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Resting sinus tachycardia is frequently encountered in cancer patients. It affects a wide variety of cancer patients and is associated with distressing symptoms. Cancer-associated resting sinus tachycardia varies in its underlying mechanism. It can stem from the tumor burden or the side effects of chemotherapy\/radiotherapy, or it can be secondary to paraneoplastic syndrome or the sequalae of cancer itself (infection, anemia, thrombosis, etc.). The clinical significance of resting sinus tachycardia extends beyond mere symptomatology, as it can potentially indicate severe complications which may facilitate or exacerbate a new or underlying cardiovascular dysfunction. Therefore, this necessitates thorough diagnostic tools to discern the underlying cause and tailor appropriate management strategies, whether pharmacological, non-pharmacological, or conservative. While resting sinus tachycardia has been extensively investigated in the context of cardiovascular disease, its underlying etiology, clinical implication, prognostic value, and treatment options remain vague in the context of cancer. This review aims to explore the topic of resting sinus tachycardia in cancer patients through delving deeper into its underlying mechanism, presenting the current evidence on its effect on cancer-independent cardiovascular and all-cause mortality, as well as providing some insight into the currently available treatment options. It will also propose therapeutic interventions and strategies aimed at optimizing cancer patient care. Lastly, it will highlight research gaps which need to be addressed further, as future research is needed to refine the diagnostic criteria, develop targeted therapies, find alternative cardioprotective\/cardio-neutral chemotherapy options, and establish evidence-based guidelines to improve outcomes in this vulnerable patient population.<\/jats:p>","DOI":"10.3390\/jcm14030985","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:55:22Z","timestamp":1738648522000},"page":"985","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring Resting Sinus Tachycardia in Cancer Care: A Comprehensive Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Yeva","family":"Fakih","sequence":"first","affiliation":[{"name":"Faculty of Medicine, American University of Beirut Medical Center, Beirut 1107, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5335-5566","authenticated-orcid":false,"given":"Moied","family":"Al Sakan","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, American University of Beirut Medical Center, Beirut 1107, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaaeddine","family":"El Ghazawi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, American University of Beirut Medical Center, Beirut 1107, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Khoury","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, American University of Beirut Medical Center, Beirut 1107, Lebanon"},{"name":"Internal Medicine Department, American University of Beirut Medical Center, Beirut 1107, Lebanon"},{"name":"Cardiology Department, Division of Cardiac Electrophysiology, American University of Beirut Medical Center, Beirut 1107, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-1987","authenticated-orcid":false,"given":"Marwan M.","family":"Refaat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, American University of Beirut Medical Center, Beirut 1107, Lebanon"},{"name":"Internal Medicine Department, American University of Beirut Medical Center, Beirut 1107, Lebanon"},{"name":"Cardiology Department, Division of Cardiac Electrophysiology, American University of Beirut Medical Center, Beirut 1107, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cjca.2016.04.008","article-title":"Shared risk factors for cardiovascular disease and cancer: Implications for preventive health and clinical care in oncology patients","volume":"32","author":"Johnson","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/cvr\/cvz058","article-title":"Inflammation: A common contributor to cancer, aging, and cardiovascular diseases\u2014Expanding the concept of cardio-oncology","volume":"115","author":"Libby","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ijcard.2016.06.330","article-title":"The dawn of a new era in onco-cardiology: The Kumamoto Classification","volume":"220","author":"Sueta","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/oxfordjournals.eurheartj.a015465","article-title":"The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality","volume":"18","author":"Mensink","year":"1997","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: The Framingham study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00392-013-0644-4","article-title":"Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: An analysis of ONTARGET\/TRANSCEND","volume":"103","author":"Lonn","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2013.11.027","article-title":"Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"63","author":"Opdahl","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11906-013-0342-7","article-title":"Heart Rate and the Cardiometabolic Risk","volume":"15","author":"Palatini","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jjcc.2012.06.013","article-title":"Heart rate as a target of treatment of chronic heart failure","volume":"60","author":"Hori","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/01.RES.36.6.199","article-title":"Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension","volume":"36","author":"Julius","year":"1975","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"New Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.21037\/jtd-21-779","article-title":"Associations between sinus tachycardia and adverse cardiovascular outcomes and mortality in cancer patients","volume":"13","author":"Hemu","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5114\/aoms.2013.34574","article-title":"Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: A pilot feasibility study","volume":"2","author":"Lainscak","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000338335","article-title":"Anthracycline-induced cardiotoxicity: Cardiac monitoring by continuous wave-doppler ultrasound cardiac output monitoring and correlation to echocardiography","volume":"35","author":"Geiger","year":"2012","journal-title":"Onkologie"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/jcecho.jcecho_37_24","article-title":"Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review","volume":"34","author":"Trimarchi","year":"2024","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention","volume":"1257","author":"Bhagat","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11886-018-1010-y","article-title":"Cardiovascular Autonomic Dysfunction in Patients with Cancer","volume":"20","author":"Coumbe","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.33588\/rn.3506.2002013","article-title":"Fisiologia del sistema nervioso aut\u00f3nomo [Physiology of the autonomic nervous system]","volume":"35","author":"Navarro","year":"2002","journal-title":"Rev. De Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"R1066","DOI":"10.1152\/ajpregu.00167.2003","article-title":"Interactions within the intrinsic cardiac nervous system contribute to chronotropic regulation","volume":"285","author":"Randall","year":"2003","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4330\/wjc.v7.i4.204","article-title":"Autonomic and endocrine control of cardiovascular function","volume":"7","author":"Gordan","year":"2015","journal-title":"World J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R927","DOI":"10.1152\/ajpregu.00452.2003","article-title":"Heart rate variability","volume":"285","author":"Stauss","year":"2003","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_23","first-page":"1","article-title":"Changes in heart rate during activity and Recovery","volume":"9","year":"2022","journal-title":"Ital. J. Sports Rehabil. Posturology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1439415","DOI":"10.3389\/or.2024.1439415","article-title":"Cancer-Induced Resting Sinus Tachycardia: An Overlooked Clinical Diagnosis","volume":"18","author":"Sakellakis","year":"2024","journal-title":"Oncol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1782","article-title":"Increased resting heart rate and prognosis in treatment-na\u00efve unselected cancer patients: Results from a prospective observational study","volume":"22","author":"Anker","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10654-022-00898-x","article-title":"Stress-related disorders and subsequent cancer risk and mortality: A population-based and sibling-controlled cohort study in Sweden","volume":"37","author":"Tian","year":"2022","journal-title":"Eur. J. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100402","DOI":"10.1016\/j.lanepe.2022.100402","article-title":"Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study","volume":"18","author":"Tian","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/21548331.2018.1530831","article-title":"Cardiotoxicity of cancer chemotherapy in clinical practice","volume":"47","author":"Jain","year":"2019","journal-title":"Hosp. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/OTT.S60114","article-title":"Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis","volume":"7","author":"Vyas","year":"2014","journal-title":"OncoTargets Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","article-title":"Cardiac inflammation and fibrosis following chemo\/radiation therapy: Mechanisms and therapeutic agents","volume":"30","author":"Yang","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_32","first-page":"1","article-title":"Effects of radiotherapy in coronary artery disease","volume":"21","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_33","unstructured":"Hufnagle, J.J., Andersen, S.N., and Maani, E.V. (2024). Radiation-Induced Cardiac Toxicity. StatPearls [Internet], StatPearls Publishing. Updated 29 May 2023."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.amjcard.2013.07.031","article-title":"Cardiovascular complications of radiotherapy","volume":"112","author":"Lee","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccl.2019.07.008","article-title":"Cardiotoxicity of immune therapy","volume":"37","author":"Ganatra","year":"2019","journal-title":"Cardiol. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2020.08.033","article-title":"Cardiotoxic mechanisms of cancer immunotherapy\u2014A systematic review","volume":"323","author":"Lobenwein","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2019.05.028","article-title":"Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab","volume":"292","author":"Quagliariello","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00325481.2021.1995263","article-title":"Is heart rate in post-hematopoietic stem cell transplant patients clinically relevant?","volume":"134","author":"Mathur","year":"2022","journal-title":"Postgrad. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Trimarchi, G., Teresi, L., Licordari, R., Pingitore, A., Pizzino, F., Grimaldi, P., Calabr\u00f2, D., Liotta, P., Micari, A., and de Gregorio, C. (2024). Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers. Biomedicines, 12.","DOI":"10.3390\/biomedicines12051051"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: Results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10549-016-3938-1","article-title":"Resting heart rate as a prognostic factor for mortality in patients with breast cancer","volume":"159","author":"Lee","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"M\u0119drek, S., and Szmit, S. (2022). Baseline Electrocardiographic and Echocardiographic Assessment May Help Predict Survival in Lung Cancer Patients\u2014A Prospective Cardio-Oncology Study. Cancers, 14.","DOI":"10.3390\/cancers14082010"},{"key":"ref_43","unstructured":"American College of Cardiology (2024, December 01). Tachycardia in Cancer Patients May Signal Increased Mortality Risk. Available online: https:\/\/www.acc.org\/about-acc\/press-releases\/2019\/01\/25\/14\/19\/tachycardia-in-cancer-patients-may-signal-increased-mortality-risk."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2022.04.019","article-title":"Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management: JACC Review Topic of the Week","volume":"79","author":"Ahmed","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1573403X13666171129183826","article-title":"Challenges in Treatment of Inappropriate Sinus Tachycardia","volume":"14","author":"Ruzieh","year":"2018","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2459\/JCM.0000000000001203","article-title":"Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: A long-term follow-up study","volume":"22","author":"Martino","year":"2021","journal-title":"J. Cardiovasc. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1540-8167.1995.tb00391.x","article-title":"Inappropriate sinus tachycardia: Evaluation and therapy","volume":"6","author":"Krahn","year":"1995","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/europace\/eus204","article-title":"Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy","volume":"15","author":"Ptaszynski","year":"2013","journal-title":"Europace"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2012.07.074","article-title":"Inappropriate sinus tachycardia","volume":"61","author":"Olshansky","year":"2013","journal-title":"J. Am. Coll.Cardiol."},{"key":"ref_50","first-page":"e22968","article-title":"A case of severe dilated cardiomyopathy and hyperthyroidism","volume":"14","author":"Haidous","year":"2022","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00392-007-0500-5","article-title":"Selective inhibition of the pacemaker channel If improves symptoms in severe dilated cardiomyopathy","volume":"96","author":"Hoppe","year":"2007","journal-title":"Clin. Res. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jccase.2020.11.016","article-title":"Implication of heart rate optimization in patients with heart failure","volume":"23","author":"Hori","year":"2021","journal-title":"J. Cardiol. Cases"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jccase.2021.05.010","article-title":"Inappropriate sinus tachycardia-induced cardiomyopathy with severe functional mitral regurgitation and successful treatment with ivabradine","volume":"25","author":"Inamori","year":"2022","journal-title":"J. Cardiol. Cases"},{"key":"ref_54","first-page":"172","article-title":"Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy","volume":"31","author":"Jeong","year":"2008","journal-title":"Clin. Cardiol. Int. Index. Peer-Rev. J. Adv. Treat. Cardiovasc. Dis."},{"key":"ref_55","first-page":"305","article-title":"Early short-term ivabradine treatment in new-onset acute systolic heart failure and sinus tachycardia patients with inflammatory rheumatic disease","volume":"18","author":"Wu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_56","first-page":"e62638","article-title":"Novel use of ivabradine for persistent sinus tachycardia in a patient on extracorporeal life support with right ventricular dysfunction","volume":"16","author":"Akopyan","year":"2024","journal-title":"Cureus"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.4022\/jafib.2395","article-title":"Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes","volume":"13","author":"Lakkireddy","year":"2020","journal-title":"J. Atr. Fibrillation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2022.07.041","article-title":"Targeted treatment of inappropriate sinoatrial node tachycardia based on electrophysiological and structural mechanisms","volume":"183","author":"Pannone","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_59","first-page":"609","article-title":"[Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients]","volume":"25","author":"Lai","year":"2006","journal-title":"Aizheng"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2169\/internalmedicine.9818-22","article-title":"Implication of ivabradine in patients with acute heart failure and sinus tachycardia following allogenic hematopoietic cell transplantation","volume":"62","author":"Henmi","year":"2023","journal-title":"Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMc1905730","article-title":"More on ivabradine in tachycardia with paraganglioma","volume":"380","author":"Scagliola","year":"2019","journal-title":"New Engl. J. Med."},{"key":"ref_62","first-page":"e18731","article-title":"Ivabradine for Chemotherapy-Related Cardiac Dysfunction in Breast Cancer","volume":"13","author":"Harada","year":"2021","journal-title":"Cureus"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dkae103","article-title":"Triazole antifungal drug interactions\u2014Practical considerations for excellent prescribing","volume":"79","author":"Lewis","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kourek, C., Touloupaki, M., Rempakos, A., Loritis, K., Tsougkos, E., Paraskevaidis, I., and Briasoulis, A. (2022). Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9080259"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","article-title":"Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101\u2013Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity","volume":"35","author":"Pituskin","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/EDBK_286019","article-title":"Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment\u2013Related Cardiovascular Toxicity","volume":"40","author":"Dent","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"H722","DOI":"10.1152\/ajpheart.01249.2004","article-title":"Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis","volume":"289","author":"Soares","year":"2005","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_68","first-page":"CD005008","article-title":"Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy","volume":"2020","author":"Kremer","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and Preventing Anthracycline-Related Cardiotoxicity","volume":"38","author":"Armenian","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_70","unstructured":"Johnson, M., and Keyes, D. (2024). Anthracycline Toxicity. StatPearls, StatPearls Publishing."},{"key":"ref_71","first-page":"2173","article-title":"Risk factors for anthracycline-associated cardiotoxicity","volume":"24","author":"Reinbolt","year":"2015","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1634\/theoncologist.8-suppl_2-17","article-title":"Cardiac safety of liposomal anthracyclines","volume":"8","author":"Safra","year":"2003","journal-title":"Oncologist"},{"key":"ref_73","first-page":"CD012738","article-title":"Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy","volume":"2018","author":"Nicolas","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2021.09.1366","article-title":"Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals","volume":"78","author":"Refaat","year":"2021","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:26:36Z","timestamp":1760027196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14030985"],"URL":"https:\/\/doi.org\/10.3390\/jcm14030985","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]}}}